Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 28, 2024

Neoadjuvant Chemoradiation Followed by FOLFIRINOX for Stage II/III Rectal Cancer

Clinical Colorectal Cancer

 

Additional Info

Clinical Colorectal Cancer
Brazil-TNT: A Randomized Phase 2 Trial of Neoadjuvant Chemoradiation Followed by FOLFIRINOX Versus Chemoradiation for Stage II/III Rectal Cancer
Clin Colorectal Cancer 2024 Sep 01;23(3)238-244, DDG Bugano, VM Santos, A Campos-Bragagnoli, JCM Melo, LGC Romagnolo, O Barbosa Neto, IT Carvalho, J Karassawa-Helito, CD Ortega, CF Tridente, LS Gerbasi, F Tustumi, PB Giovani Blasi, M Novaes Figueiredo de Araujo, RV Pandini, VE Seid, AS Portilho, A Buosso, F Rolla, GPP Schettino, SEA Araujo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading